logo

Madrigal Pharmaceuticals, Inc. (MDGL)



Trade MDGL now with
  Date
  Headline
5/8/2018 6:51:52 AM Madrigal Pharma Q1 Loss Per Share $0.45 Vs Loss $0.50 Last Year
3/13/2018 6:51:54 AM Madrigal Pharma Q4 Loss Per Share $0.67, Flat With Last Year
2/8/2018 6:52:19 AM Madrigal’s MGL-3196 Achieves Primary Endpoint In Patients With Heterozygous Familial Hypercholesterolemia
1/30/2018 7:04:31 AM Madrigal Announces Acceptance Of MGL-3196 Abstract For Main Plenary Presentation At International Liver Congress 2018
12/18/2017 11:37:23 PM Madrigal Pharma Prices Public Offering Of 1.51 Mln Common Stock At $83/Shr
12/18/2017 6:53:01 AM Madrigal Pharma Commences Underwritten Public Offering Of $100 Mln Of Common Stock
11/9/2017 7:54:32 AM Madrigal Q3 Loss Per Share $0.68 Vs Loss $1.59 Prior Year
9/19/2017 7:39:32 AM Madrigal Pharma Says Positive Outcome From DSMB Safety Review; Completes Enrollment Of Phase 2 Study Of MGL-3196